-
公开(公告)号:HK1054375A1
公开(公告)日:2003-11-28
申请号:HK03104885
申请日:2003-07-08
Applicant: ABBOTT LAB
Inventor: MICHAEL R SCHRIMPF , KARIN R TIETJE , RICHARD B TOUPENCE , JIANGUO JI , ANWER BASHA , WILLIAM H BUNNELLE , JEROME F DAANEN , JENNIFER M PACE , KEVIN B SIPPY
IPC: C07D20060101 , C07D231/54 , A61K31/454 , A61K31/4545 , A61P25/00 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/24 , A61P25/28 , A61P25/34 , C07D471/04 , C07D487/04
-
2.
公开(公告)号:ZA200602274B
公开(公告)日:2007-11-28
申请号:ZA200602274
申请日:2006-03-17
Applicant: ABBOTT LAB
Inventor: ANWER BASHA , DART MICHAEL J , JIANGUO JI , RYTHER KEITH B , MORTELL KATHLEEN H , SCHRIMPF MICHAEL R , BUNNELLE WILLIAM H , GALLAGHER MEGAN E , PACE JENNIFER M , TIETJE KARIN R , NERSESIAN DIANA L , TAO LI
IPC: A61K20090101 , A61K31/435 , A61P20090101 , A61P25/00 , C07D20090101 , C07D471/04 , C07D471/08 , C07D487/04 , C07D487/08
Abstract: Compounds of formula (I) Z-Ar 1 -Ar 2 wherein Z is a diazabicyclic amine, Ar 1 is a 5- or 6-membered aromatic ring, and Ar 2 is selected from the group consisting of an unsubstituted or substituted 5-or 6-membered heteroaryl ring; unsubstituted or substituted bicyclic heteroaryl ring; 3,4-(methylenedioxy)phenyl; carbazolyl; tetrahydrocarbazoyl; naphthyl; and phenyl; wherein the phenyl is substituted with 0, 1, 2, or 3 substituents in the meta- or para-positions. The compounds are useful in treating conditions or disorders prevented by or ameliorated by ±7 nAChR ligands. Also disclosed are pharmaceutical compositions comprising compounds of formula (I) and methods for using such compounds and compositions.
-
公开(公告)号:CO4970740A1
公开(公告)日:2000-11-07
申请号:CO98047584
申请日:1998-08-20
Applicant: ABBOTT LAB
Inventor: BLACK LAWRENCE A , ANWER BASHA , TEODOZYJ KOLOSA , KORT MICHAEL E , HUAQING LIU , MC CARTY CATHERINE M , MEENA V PATEL , ROHDE JEFFREY J
IPC: A61K31/12 , A61K31/38 , A61K31/50 , C07D237/14 , C07D237/18 , C07D401/06 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/06 , C07D409/06 , C07D409/12 , C07D417/06
Abstract: Un compuesto de fórmula I: en dondeX se selecciona del grupo conformadopor O, S, NR4 , N-ORa , y N-NRb Rc , en donde R4 se selecciona del grupo conformado por alquil, alquenil, cicloalquil, cicloalquenil, cicloalquilalquil, cicloalquenilalquil, aril, heterocíclico, heterocíclico alquil, y arilalquil; y Ra , Rb , y Rc se seleccionan independientemente del grupo conformado por alquil, cicloalquil, cicloalquilalquil, aril, y arilalquil; R se selecciona del grupo conformado por alquil, alquenil, alquinil, alquilcarbonilalquil, alquilsulfonilalquil, alquilsulfonilarilalquil, alcoxi, alcoxialquil, carboxi, carboxialquil, cianoalquil, haloalquil, haloalquenil, haloalquinil, hidroxialquil, cicloalquil, cicloalquilalquil, cicloalquenil, cicloalquenilalquil, aril, arilalquil, arilalquenil, arilalquinil, arilalcoxi, arilhaloalquil, arilhidroxialquil, ariloxi, ariloxihidroxialquil, ariloxihaloalquil, arilcarbonilalquil, haloalcoxihidroxialquil, heterocíclico, heterocíclico alquil, heterocíclico alcoxi, heterocíclico oxi, -C(O)R5 , -(CH2 )n C(O)R5 , -R6 -R7 , -(CH2 )n CH(OH)R5 , (CH2 )n CH(ORd )R5 , (CH2 )n C(NORd )R5 , (CH2 )n C(NRd )R5 , -(CH2 )n CH(NORd )R5 , -(CH2 )n CH(NRd Re )R5 , -(CH2 )n CºC-R7 , -(CH2 )n [CH(CX´3 )]m -(CH2 )n -CX´3 , -(CH2 )n (CX´2 )m -(CH2 )n -CX´3 , -(CH2 )n [CH(CX´3 )]m -(CH2 )n R8 , -(CH2 )n (CX´2 )m -(CH2 )n -R8 , (CH2 )n (CHX´)m -(CH2 )n -CX´3 , -(CH2 )n (CHX´)m -(CH2 )n -R8 y -(CH2 )n -R20 , en donde R5 se selecciona del grupo conformado por alquil, alquenil, alquinil, cicloalquil, cicloalquenil, aril, arilalquil, haloalquil, haloalquenil, haloalquinil, heterocíclico, y heterocíclico alquil; en donde R6 es alquileno ó alquenileno, alquileno sustituido con halo ó alquenileno sustituido con halo; ...
-
-